Novel Tumor-Agnostic Agent: 80% RR, but Target Is Rare
Oral larotrectinib is highly effective in up to 80% of metastatic solid tumors with a TRK fusion, regardless of patient age or tumor type, but these TRK fusions are...
2 days ago - Medscape
Breast MRIs May Lead to More Biopsies That Catch Fewer Cancers
Women who get magnetic resonance imaging screening tests for breast cancer are more likely to get invasive surgical biopsies to look for tumors than women who just get...
8 days ago - Medscape
Tumor-targeted Fluorescence May Help Pinpoint Colorectal Cancer During Surgery
Reuters Health Information
15 days ago - Medscape
Cell phone radiation exposure found to give rats CANCER
A new study released by the National Institutes of Health shows that exposure to cell phone radiation known as RFR causes male rats to develop a rare type of cancer. According...
16 days ago - Natural News - 4 articles
Cancer Vaccine Works 'Startlingly Well' in Mouse Model
An experimental cancer vaccine that was injected directly into the tumor cured 87 of 90 mice, including some with spontaneous tumors. Medscape Medical News
16 days ago - Medscape
A DOAC Provides Heparin Alternative to Cancer Patients
Cancer patients face an increased risk for venous thromboembolism. Under current guidelines, cancer patients who develop VTE are prescribed low-molecular-weight heparin as an...
21 days ago - Modern Medicine
'New Tool' in Arsenal for Second-Line Treatment of GEP-NETs
A new first-in-class radionuclide therapy offers an option for patients with gastroenteropancreatic neuroendocrine tumors . Medscape Medical News
23 days ago - Medscape
Novel Radiopharmaceutical Approved for GEP-NETs
A novel radiopharmaceutical, lutetium Lu 177 dotatate , has been approved by the FDA for use in gastroenteropancreatic neuroendocrine tumors. FDA Approvals
29 days ago - Medscape - 2 articles
Study could explain link between high-cholesterol diet and colon cancer
Scientists discovered that boosting mice's cholesterol levels spurred intestinal stem cells to divide more quickly, enabling tumors to form 100 times faster. The study...
30 days ago - ScienceDaily
Novel CTC Assay Detects Early-Stage Colorectal Cancer
A novel assay for circulating tumor cells was able to detect colorectal cancer at an early stage as well as precancerous lesions with high accuracy. Medscape Medical News
1 month ago - Medscape